Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics

Compound Kushen Injection (CKI) has been clinically used in China for over 15 years to treat various types of solid tumours. However, because such Traditional Chinese Medicine (TCM) preparations are complex mixtures of plant secondary metabolites, it is essential to explore their underlying molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Zhipeng, Cui, Jian, Harata-Lee, Yuka, Aung, Thazin Nwe, Feng, Qianjin, Raison, Joy M., Kortschak, Robert Daniel, Adelson, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323210/
https://www.ncbi.nlm.nih.gov/pubmed/27602759
http://dx.doi.org/10.18632/oncotarget.11788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323210/
https://www.ncbi.nlm.nih.gov/pubmed/27602759
http://dx.doi.org/10.18632/oncotarget.11788

Ejemplares similares